- Filed
- Feb 27, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Feb 19, 2024 | 4.21M sh |
| Shares Diluted restated | FY 2023 · Dec 31, 2022 | 4.06M sh |
| Capex | FY 2023 · Dec 31, 2022 | $28.15M |
| Operating Cash Flow | FY 2023 · Dec 31, 2022 | −$65.51M |
| Cash And Equivalents | FY 2023 · Dec 31, 2022 | $83.14M |
| Stockholders Equity | FY 2023 · Dec 31, 2022 | $43.96M |
| Current Liabilities | FY 2023 · Dec 31, 2022 | $116.52M |
| Total Liabilities | FY 2023 · Dec 31, 2022 | $890.2M |
| Current Assets | FY 2023 · Dec 31, 2022 | $194.13M |
| Total Assets | FY 2023 · Dec 31, 2022 | $1.08B |
| Eps Diluted restated | FY 2023 · Dec 31, 2022 | −$125.59 |
| Eps Basic restated | FY 2023 · Dec 31, 2022 | −$125.59 |
| Sga Expense | FY 2023 · Dec 31, 2022 | $114.72M |
| Net Income | FY 2023 · Dec 31, 2022 | −$492.38M |
| Operating Income | FY 2023 · Dec 31, 2022 | −$539.73M |
| Revenue | FY 2023 · Dec 31, 2022 | $635.67M |